z-logo
open-access-imgOpen Access
Is febuxostat associated with higher risk of cardiovascular death than allopurinol in treating gout or asymptomatic hyperuricemia?
Author(s) -
Jian-Hao Deng,
Guo-Wei Zhong,
Jiaxing Zhang
Publication year - 2022
Publication title -
annals of palliative medicine
Language(s) - English
Resource type - Journals
eISSN - 2224-5839
pISSN - 2224-5820
DOI - 10.21037/apm-22-618
Subject(s) - medicine , febuxostat , hyperuricemia , allopurinol , gout , asymptomatic , intensive care medicine , uric acid , cardiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom